Statistics from Altmetric.com
In a retrospective case note study of patients referred to a specialist clinic for motor neuron disorders we identified a subgroup of patients with severe wasting and weakness of the arms without significant functional involvement of other regions. This “flail arm syndrome” was identified in 39/395 (10%) of the subjects studied. Their clinical characteristics were compared with the amyotrophic lateral sclerosis (ALS) group as a whole. The age of onset was similar between the two groups but the male:female ratio was 9:1 in the flail arm group, compared with 1.5:1 in the ALS group (p=0.0015). Although there was a trend towards improved survival in the flail arm group (median survival 57 (95%CI 45–69) months) compared with the ALS group (39 (95%CI 35–43) months), this did not reach significance (p=0.204) and was not an independent prognostic factor. As many patients with flail arm syndrome develop upper motor neuron signs in the lower limbs this syndrome probably represents a variant of ALS. It seems likely that unknown factors linked to male sex predispose a proportion of patients to develop the flail arm phenotype.
Historically, physicians have categorised illnesses according to their clinical characteristics. As a result the adult sporadic motor neuron disease syndromes have been described according to the site of lesion onset. Most patients present with both upper and lower motor neuron signs in the limbs (classic motor neuron disease or ALS). Rarer forms of predominantly upper and lower motor neuron syndromes are also recognised (primary lateral sclerosis and progressive muscular atrophy respectively). We have noted that a subgroup of patients with classic ALS present with progressive wasting and weakness of the arms, with little or no functional impairment of the bulbar muscles or legs (figure). Here we describe their clinical features and natural history in comparison to the ALS group as a whole. We have used the term “flail arm syndrome” to describe this variant of ALS.
All patients attending our specialist motor neuron disorders clinic between 1 January 1990 and 30 September 1996 were studied in a retrospective case notes study. Patients with alternative diagnoses, such as Kennedy’s disease, spinal muscular atrophy, and multifocal motor neuropathy were excluded after full genetic, neurophysiological, and serological investigation, leaving 395 patients with a firm diagnosis of ALS. The censoring date for survival analysis was 31 January 1996. Patients were classified according to the El Escorial criteria1 and included in a detailed database incorporating key characteristics of the disease. Most fulfilled probable or definite ALS El Escorial catagories having upper and lower motor neuorn signs at first review. A minority with predominantly lower motor neuron features at presentation fulfilled suspected or possible ALS El Escorial catagories. The flail arm syndrome was defined as a predominantly lower motor neuron disorder of the upper limbs without significant functional involvement of other regions at clinical presentation. Specifically, the wasting and weakness of the upper limbs had to be profound, symmetric, and involve proximal muscle groups (MRC grade ⩽3). Those fulfilling the flail arm criteria were identified and compared with the rest of the ALS population based on the clinical assessment made at the time of the first clinic visit. Follow up was complete.
Demographic variables were compared using Student’s ttest. The χ2 test and linear regression were used to test the independence of two variables. Survival of patients with ALS was estimated using the Kaplan-Meier curves and the log rank test was used to compare different categories. The Cox proportional hazards model was used to assess the simultaneous effects of several variables on survival. Results are expressed as the mean ±1 SD and a p value of <0.05 was considered significant.
Of 395 patients, 39 (10%) were identified as having the flail arm syndrome. Nine out of 39 (23%) of the patients with the syndrome had solely lower motor neuron features at the time of presentation. Upper motor neuron signs in the legs were present in most patients (77%) and although bulbar signs were present in 22 (56%) during the follow up period they were commonly asymptomatic at presentation.
The male to female ratio was strikingly different between the two groups, being 9:1 in the flail arm group and 1.5:1 in the ALS group (Student’s t test, p=0.0015). The mean age of symptom onset was similar (flail arm 58 (SD 13) years and ALS 55 (SD12) years) and there was no significant difference in the duration of follow up (flail arm 24 (SD 17) months and ALS 20 (SD 13) months, p=0.17) or the proportion of familial cases (both 9%).
Using Kaplan-Meier analysis, the median survival in the flail arm group was 57 (95%CI 45–69; range 6–109) months, compared with 39 (95%CI 35–43; range 2–577) months in the ALS group, but this did not reach significance (log rank test, p=0.204). There was no significant difference between the mean survival of flail arm and limb onset ALS groups. Using the Cox proportional hazards model, the flail arm syndrome was not identified as an independent risk factor determining survival.
The features of this distinctive ALS variant have not previously been characterised but it was probably first described by Gowers in his 1888 text Diseases of the Nervous System. In the chapter on the progressive muscular atrophies he noted that “when the arms are the seat of (such) atrophy as has been described, the legs, if not also wasted, may be normal, but they are often paralysed without being wasted“ suggesting a pyramidal lower limb weakness.2Indeed, the illustration of a patient with primary muscular atrophy depicts the typical appearance of the patient with flail arm syndrome.
The predominant clinical feature of this syndrome is the relatively symmetric and proximal involvement of both arms, causing severe wasting and functional disability, with little or no weakness of the leg or bulbar musculature. Signs of corticospinal tract involvement are common in the legs and although denervation may be present in other regions this pattern of flail arms may persist for many years. Despite a severe loss of motor neurons in the cervical cord of patients with flail arm syndrome the higher cervical segments innervating the diaphragm seem to be spared early in the course of the disease.
What is the relation between the flail arm syndrome and other forms of ALS? The demonstration of upper motor neuron signs in most patients distinguishes this syndrome from primary muscular atrophy although there is probably an overlap. Our findings suggest that in most instances the flail arm syndrome represents a variant of classic ALS and most patients fulfil the probable or definite ALS El Escorial categories.1 Although our clinic based ALS population is selected by referral it seems to be broadly representative judging by the demographic features described in other clinic and population samples.3 4
We, and others, have previously reported the influence of genotype on ALS phenotype with the apolipoprotein E ε4 allele being associated with a bulbar onset of disease.5 6 It is interesting to note that whereas the male:female ratio in most studies is around 1.5:1 for ALS overall, women predominate in the late onset bulbar palsy group.3 4 The most striking finding of our study is the predominance of males in the flail arm group with a ratio of 9:1. It may be that factors linked to male sex predispose a proportion of patients to develop the flail arm phenotype. Curiously a male preponderance is also described in other lower motor neuron syndromes such as multifocal motor neuronopathy and monomelic amyotrophy.7 8
We suspect that survival of patients with flail arm syndrome might be better than those with other forms of ALS as the median survival in the flail arm group was 57 months, compared with 39 months in the ALS group. Although the difference was not significant, our numbers are still small and larger studies are needed. We conclude that the flail arm syndrome is a distinctive clinical variant of ALS that is strikingly more common in males and may have a better prognosis.